These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22018756)

  • 1. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis.
    Kimball AB; Szapary P; Mrowietz U; Reich K; Langley RG; You Y; Hsu MC; Yeilding N; Rader DJ; Mehta NN
    J Am Acad Dermatol; 2012 Jul; 67(1):76-85. PubMed ID: 22018756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cardiovascular risk factors in patients with psoriasis.
    Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
    J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.
    Rosa DJ; Machado RF; Matias FA; Cedrim SD; Noronha FL; Gaburri D; Gamonal A
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):348-53. PubMed ID: 21545540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.
    Reich K; Langley RG; Lebwohl M; Szapary P; Guzzo C; Yeilding N; Li S; Hsu MC; Griffiths CE
    Br J Dermatol; 2011 Apr; 164(4):862-72. PubMed ID: 21332467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts.
    Volf EM; Levine DE; Michelon MA; Au SC; Patvardhan E; Dumont N; Loo DS; Kuvin J; Gottlieb AB
    J Drugs Dermatol; 2011 Aug; 10(8):900-1. PubMed ID: 21818512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
    Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
    Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
    Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasis and cardiovascular screening rates in the United States.
    Alamdari HS; Gustafson CJ; Davis SA; Huang W; Feldman SR
    J Drugs Dermatol; 2013 Jan; 12(1):e14-9. PubMed ID: 23377342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.
    Shapiro J; Cohen AD; Weitzman D; Tal R; David M
    J Am Acad Dermatol; 2012 Feb; 66(2):252-8. PubMed ID: 21742411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists.
    Parsi KK; Brezinski EA; Lin TC; Li CS; Armstrong AW
    J Am Acad Dermatol; 2012 Sep; 67(3):357-62. PubMed ID: 22079041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of myocardial infarction in patients with psoriasis in central China.
    Xiao J; Chen LH; Tu YT; Deng XH; Tao J
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1311-5. PubMed ID: 19522710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the "typical" cardiometabolic patient for risk of cardiovascular disease.
    Strobl DJ
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S21-2. PubMed ID: 19451255
    [No Abstract]   [Full Text] [Related]  

  • 16. Goal attainment for multiple cardiovascular risk factors in community-based clinical practice (a Canadian experience).
    Farahani P; Levine M
    J Eval Clin Pract; 2009 Feb; 15(1):212-6. PubMed ID: 19239605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of patients with high cardiovascular risk in general practice].
    Ilyés I; Erdei I; Jancsó Z
    Orv Hetil; 2004 Aug; 145(33):1723-6. PubMed ID: 15462478
    [No Abstract]   [Full Text] [Related]  

  • 20. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?
    Fleischmann EH; Bower JD; Salahudeen AK
    Clin Nephrol; 2001 Sep; 56(3):221-30. PubMed ID: 11597037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.